Skip to main content
Frances Levin, MD, Psychiatry, New York, NY

FrancesRudnickLevinMD

Psychiatry New York, NY

Addiction

Associate Professor of Psychiatry, Columbia P&S

Dr. Levin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Levin's full profile

Already have an account?

  • Office

    1051 Riverside Dr RM 3625
    New York, NY 10032
    Phone+1 212-543-5896
    Fax+1 212-543-6018

Education & Training

  • University of Maryland/Sheppard Pratt
    University of Maryland/Sheppard PrattResidency, Psychiatry, 1989 - 1990
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1985 - 1988
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1986 - 2026
  • NJ State Medical License
    NJ State Medical License 2004 - 2025
  • MD State Medical License
    MD State Medical License 1988 - 1992
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Addiction Psychiatry

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2011-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2007-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Perils of Screening for Unhealthy Drug Use Are a Call to Action for the Mental Health Workforce  
    Frances Levin, MD, JAMA Psychiatry
  • American Psychiatric Association Publishing  
    Adam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health

Authored Content

  • The Perils of Screening for Unhealthy Drug Use Are a Call to Action for the Mental Health WorkforceJune 2020

Press Mentions

  • Effort Underway to Develop First US Guidelines for ADHD in Adults
    Effort Underway to Develop First US Guidelines for ADHD in AdultsApril 17th, 2023
  • AELIS FARMA : Announces a Strategic Collaboration and Option-License Agreement with INDIVIOR for the Treatment of Cannabis-Related Disorders
    AELIS FARMA : Announces a Strategic Collaboration and Option-License Agreement with INDIVIOR for the Treatment of Cannabis-Related DisordersJune 8th, 2021
  • Do Any Medications Help Ease Marijuana Dependence?
    Do Any Medications Help Ease Marijuana Dependence?March 2nd, 2020
  • Join now to see all

Grant Support

  • Substance Abuse Treatment Development And Clinical Research MentoringNational Institute On Drug Abuse2010–2011
  • Research Fellowship In Substance Abuse DisorderNational Institute On Drug Abuse2008–2011
  • Multi-Site Controlled Trial Of Cocaine Vaccine (6 Of 6) Columbia University SiteNational Institute On Drug Abuse2008–2011
  • Extended Release Mixed Amphetamine Salts For Adult ADHD And Cocaine DependenceNational Institute On Drug Abuse2007–2010
  • Treatment Of Substance Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse2000–2009
  • Combined Pharmacotherapies For Cocaine DependenceNational Institute On Drug Abuse2006–2008
  • Agonist Treatment For Marijuana DependenceNational Institute On Drug Abuse2004–2008
  • Research Fellowship In Substance Abuse DisordersNational Institute On Drug Abuse2004–2007
  • Marijuana Dependence &Depression: Venlafaxine TreatmentNational Institute On Drug Abuse2003–2006
  • Marijuana Abusing ADHD Teens: Atomoxetine TreatmentNational Institute On Drug Abuse2004
  • Novel Pharmacotherapies For Cocaine DependenceNational Institute On Drug Abuse2001–2003
  • Treatment Of Adult ADHD In Methadone PatientsNational Institute On Drug Abuse1998–2002
  • Methylphenidate Treatment For Cocaine Abuse And ADHDNational Institute On Drug Abuse1998–2002
  • Treatment Of Cocaine Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse1995–1998
  • Treatment Of Cocaine Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse1994

Professional Memberships